People: GenVec Inc (GNVC.O)

GNVC.O on Consolidated Issue listed on NASDAQ Capital Market

1.88USD
31 Oct 2014
Price Change (% chg)

-- (+0.00%)
Prev Close
$1.88
Open
$1.89
Day's High
$1.89
Day's Low
$1.83
Volume
29,508
Avg. Vol
38,835
52-wk High
$4.25
52-wk Low
$1.19

Search Stocks

Horovitz, Zola 

Brief Biography

Dr. Zola P. Horovitz, Ph.D. is no longer serves as Director of Genvec, Inc. Dr. Horovitz is currently retired. Dr. Horovitz is a member of the Nominating and Corporate Governance Committee and the Audit Committee and is the Chairman of the Board of Directors. Dr. Horovitz is currently retired. He served as a director of Diacrin, Inc. from 1994 to August 2003. From 1991 to 1994, Dr. Horovitz was Vice President, Business Development and Planning at Bristol-Myers Squibb Pharmaceutical Group and was Vice President, Licensing from 1989 to 1991. Prior to 1989, Dr. Horovitz spent 30 years as a member of the Squibb Institute for Medical Research and received his Ph.D. from the University of Pittsburgh. Dr. Horovitz currently serves as a director of Palatin Technologies, Inc. Within the past five years, Dr. Horovitz also served on the boards of BioCryst Pharmaceuticals, Inc., Genaera Corp, NitroMed, Inc., Avigen, Inc. and DoV Pharmaceutical Inc.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks